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Abstract: Tobacco use is projected to kill 1 billion people in the 21st century. Tobacco Use Disorder
(TUD) is one of the most common substance use disorders in the world. Evidence-based treatment of
TUD is effective, but treatment accessibility remains very low. A dearth of specially trained clinicians
is a significant barrier to treatment accessibility, even within systems of care that implement brief
intervention models. The treatment of TUD is becoming more complex and tailoring treatment
to address new and traditional tobacco products is needed. The Council for Tobacco Treatment
Training Programs (Council) is the accrediting body for Tobacco Treatment Specialist (TTS) training
programs. Between 2016 and 2019, n = 7761 trainees completed Council-accredited TTS training
programs. Trainees were primarily from North America (92.6%) and the Eastern Mediterranean
(6.1%) and were trained via in-person group workshops in medical and academic settings. From
2016 to 2019, the number of Council-accredited training programs increased from 14 to 22 and annual
number of trainees increased by 28.5%. Trainees have diverse professional backgrounds and work
in diverse settings but were primarily White (69.1%) and female (78.7%) located in North America.
Nearly two-thirds intended to implement tobacco treatment services in their setting; two-thirds
had been providing tobacco treatment for 1 year or less; and 20% were sent to training by their
employers. These findings suggest that the training programs are contributing to the development
of a new workforce of TTSs as well as the development of new programmatic tobacco treatment
services in diverse settings. Developing strategies to support attendance from demographically and
geographically diverse professionals might increase the proportion of trainees from marginalized
groups and regions of the world with significant tobacco-related inequities.
Keywords: smoking cessation; health care professional training; tobacco dependence treatment;
evidence-based practice
1. Introduction
While tobacco control efforts have made progress in reducing the prevalence of
cigarette smoking, Tobacco Use Disorder (TUD) is one of the most common substance use
disorders in the world [1,2] and tobacco use remains a leading cause of preventable death
and disease, responsible for more than 8 million deaths worldwide every year [3]. Over
600,000 of these deaths annually are from secondhand smoke, including 30% children [4,5].
Moreover, tobacco use has a disproportionate impact on lower socioeconomic groups [3].
Over 80% of the 1.3 billion tobacco users worldwide live in low or middle-income countries
with some of the highest rates of tobacco-related death, disease, and health care costs [6].
If current consumption rates continue, smoking cigarettes alone is projected to kill 1 billion
people in the 21st century [7,8]. Tobacco use also imposes substantial global economic bur-
dens. The average cost of smoking cigarettes globally is 1.8% of the gross domestic product
(GDP) [9], but this burden is not equally shared. Nearly 40% of this burden is shouldered by
developing countries, causing significant financial liability on already-limited budgets [10].
For example, Jordan loses 6% of its GDP to tobacco use annually [11]. Accordingly, tobacco
use is one of the leading causes of health inequities in the world [12,13].
The World Health Organization (WHO) Framework Convention on Tobacco Control
(FCTC), developed to address the worldwide proliferation of tobacco products, is fo-
cused on international efforts to reduce demand for and supply of tobacco products [14].
At present, 182 parties covering 90% of the world have joined the treaty. Article 14 of
the FCTC states that each party should take evidence-based measures to promote tobacco
cessation and provide treatment for tobacco dependence, but little progress has been made
in many parts of the world [15]. For instance, the Eastern Mediterranean has some of the
highest tobacco smoking prevalence rates in the world [16,17]. Over 42% of men in the
United Arab Emirates [18], and 70% of men in Jordan smoke cigarettes [11]. In Lebanon,
50% of men and women smoke cigarettes [16]. Nearly 20% of young people in the Eastern
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Mediterranean smoke tobacco in waterpipes [17]. The Gulf Cooperation Council (GCC:
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain) has prioritized the
reduction of tobacco smoking [19,20]. The WHO Regional Committee for the Eastern
Mediterranean lists tobacco control as a crucial part of a regional framework for action to
control premature death from non-communicable diseases [3,21].
TUD is a complex behavior influenced by powerful biological, psychological, social,
and cultural factors [22–24]. Most tobacco users want to quit and many make attempts
to quit every year, but few attempts result in long-term abstinence [25,26]. For example,
in Jordan, 57% of cigarette smokers intend to quit in the next year and 42% in the next
30 days [27]. In the US, 70% of cigarette smokers want to quit and more than half make
a quit attempt each year, but less than 10% of these attempts result in 6 months of absti-
nence [26]. Nearly 80% of tobacco users have difficulty quitting, experience withdrawal
symptoms, and continue to use tobacco despite the knowledge of the harm [23]. Moreover,
the complexity of treating TUD is increasing as new tobacco products are introduced
and combined with traditional tobacco products worldwide. In addition to traditional
cigarettes, cigars, cigarillos, and a wide variety of smokeless tobacco products, there are
hundreds of different electronic nicotine delivery systems (ENDS, e.g., e-cigarettes, vaping
devices) with thousands of flavors [28], dissolvable tobacco products, and heat-not-burn
delivery systems [29]. (See Supplementary Materials for examples of tobacco product use
common in certain regions of the world.) Detailed knowledge of this changing landscape
is required to engage in meaningful and effective discussions with tobacco users.
Evidence-based treatment of TUD dramatically increases the chances of achieving long-
term abstinence [30–32], but utilization of evidence-based approaches worldwide remains
very low [25]. The highest standard of care for TUD is evidence-based behavioral treatment
provided by highly skilled practitioners, guided by treatment manuals, and combined
with pharmacotherapy [33–38]. In the US, one of the wealthiest countries in the world,
less than one third of quit attempts are aided by evidence-based treatment and less than
5% receive the highest standard of care [25,26]. Greater use of evidence-based treatments
would result in more individuals achieving long-term abstinence more quickly and reduced
tobacco-related death, disease, and economic loss worldwide.
Lack of treatment access is a primary contributor to low utilization of evidence-based
treatments for TUD [24,39]. In addition to lack of clinician time [40–42], internationally one
of the most common barriers to providing treatment is a lack of training in the treatment of
TUD [15,40–49]. Advanced provider training is linked with improved tobacco treatment
skills and clearly improves patient outcomes [36,37,50,51]. Moreover, lack of provider
training disproportionately affects individuals with complex TUD presentations such as
individuals using multiple tobacco products, with mental health conditions, with cancer
and other chronic health conditions, and pregnant women, all of whom show clear benefits
from specialized TUD treatment [52–54].
Systematic, brief intervention models are recommended by many clinical practice
guidelines [31,55–57] and have significantly increased the number of cigarette smokers
identified and advised to quit; nevertheless, after decades of implementation, few tobacco
users are provided with evidenced-based assistance [26,58]. Complementary models,
however, that incorporate specialist treatment into brief intervention models (e.g., Ask,
Advise, Connect) and are tested in real-world settings can dramatically increase the pro-
portion of patients who receive treatment [34,36,59–62]. Recent advances in lung cancer
screening have also provided opportunities for highly trained specialists to reach high-risk
populations [63].
Although there are dozens of different tobacco treatment training programs world-
wide, little is known about the characteristics of individuals who seek advanced training in
the treatment of TUD [15,44,64]. Established in 2008, the Council for Tobacco Treatment
Training Programs (www.ctttp.org (accessed on 24 February 2021)) has developed an in-
terdisciplinary approach to implementing training standards [65] for Tobacco Treatment
Specialists (TTSs) with the goal of ensuring that TTSs are prepared to meet the needs of
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dynamic, diverse, and complex populations of tobacco users in diverse settings. As the
number of accredited training programs and trainees has grown, little is known about the
nature of the accredited programs and the trainees and whether the Council and these train-
ing efforts are well-positioned to meet the needs of tobacco users in diverse settings. This
study of the data collected by the Council from 2016–2019 aimed to examine the nature of
the training programs, the characteristics of the trainees, and to make recommendations for
developing a tobacco treatment workforce that meets tobacco treatment needs worldwide.
2. Materials and Methods
Council accreditation requires a TTS training program to complete a formal application
and review process, often with guidance provided by Council reviewers. Each application
describes the nature of the training program, the target treatment population, and other
unique characteristics in detail, including its goals and objectives, faculty, and process
for inviting professionals, who serve culturally and linguistically diverse populations.
The application requires the program to demonstrate how they teach each of the required
skills, how they engage in self-evaluation, and how they evaluate trainee learning. The ap-
plication is reviewed by the Board of Councilors, experts in the field, and accreditation is
awarded when the Board of Councilors determines that the training program meets all the
training standards. Continued accreditation is subject to annual review.
All Council-accredited training programs meet the same minimum training standards,
but differ in their missions, settings, training models, training modalities, and the tailored
focus they provide trainees. Successful completion of a Council-accredited TTS training
program is necessary to be eligible for the National Certificate of Tobacco Treatment Practice
(NCTTP) (https://www.naadac.org/NCTTP (accessed on 24 February 2021)).For instance,
some programs, such as Optum’s Quit for Life, National Jewish Health®, MercyCare,
and Healthways, train professionals only within their organizations. While most programs
train professionals on their campuses, many programs also travel to other sites, nationally
and internationally, to provide training. From 2016–2019 most programs provided the bulk
of the training via in-person workshops.
In 2016 and 2017, the Council, in collaboration with the training programs, imple-
mented mandatory reporting. In 2016, all programs were required to report the number
of trainees trained annually. In 2017, the collection of a minimal common set of data from
trainees was implemented. This data is collected by the programs, generally prior to
training, and reported in a de-identified manner to the Council by January 31 following
the reporting year. The minimal data set includes basic demographic information as well
as professional background, work setting, experience in the treatment of tobacco depen-
dence, and reasons for seeking training including: “I want to treat tobacco users,” “My
organization is requiring me to,” “I want to get certified,” “I want to learn more about the
field of tobacco treatment,” and “I want to do research.” Trainees can identify more than
one reason.
Data was compiled by the Council management (Jessica Retzlaff) and analyzed by
Drs. Carl and Sheffer. Descriptive analyses were conducted for all variables (range,
means, standard deviations, frequencies, percentages). Pearson correlation coefficient was
calculated between the number of hours per week devoted to tobacco treatment and the
number of years working in tobacco treatment. Professional background and work setting
were categorized within common professional themes. For example, registered, licensed,
surgical, hospice, and palliative care nurses were categorized under nursing.
3. Results
Between 2016 and 2019, n = 7761 trainees completed Council-accredited TTS training
programs; n = 2274 in 2019; n = 1829 in 2018; n = 1888 in 2017, and n = 1770 in 2016.
Trainee characteristics were available for 86.8% of trainees in years 2017–2019 (n = 5203
total; n = 2227 in 2019; n = 1656 in 2018; and n = 1320 in 2017). Trainees resided in six
international regions: North America (n = 4519), Middle East (n = 297), Europe (n = 38), Asia
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(n = 15), Africa (n = 11), and Australia (n = 1); were predominantly White (69.1%), women
(78.7%), and had completed at least some college education (93%). See Table 1. From 2016
to 2019, the annual number of trainees increased by 28.5%. See Table 2. A complete list of
training programs accredited through 2020 is included in Table 3.
Table 1. Characteristics of Training Program Trainees.
Number of Accredited Programs Total 2019 2018 2017
22 22 20 19







Variable Range or Categories
Age (mean) 17–84 40.43 (12.33) 39.60 (12.49) 41.83 (12.01) 40.19 (12.29)
N (%) N (%) N (%) N (%)
Sex/Gender Female 3785 (78.7) 1585 (77.8) 1181 (78.3) 1019 (80.6)
Race/Ethnicity
White/Caucasian 3063 (69.1) 1376 (70.8) 956 (68.7) 731 (66.5)
Black/African American 604 (13.6) 259 (13.3) 200 (14.4) 145 (13.2)
Asian 282 (6.4) 104 (5.4) 82 (5.9) 96 (8.7)
American
Indian/Alaska Native 95 (2.1) 30 (1.5) 29 (2.1) 36 (3.3)
Native
Hawaiian/Pacific Islander 31 (0.7) 16 (0.8) 14 (0.9) 1 (0.1)
Hispanic of any race 358 (8.1) 158 (8.1) 110 (7.9) 90 (8.2)
Education
level
High school or less 299 (7.0) 223 (10.7) 41 (2.8) 35 (4.9)
Some college, associate degree,
and other 535 (12.5) 257 (12.3) 198 (13.6) 77 (10.7)
Bachelor’s degree 1398 (32.7) 681 (32.7) 491 (33.3) 226 (31.5)
Master’s degree 1486 (34.8) 655 (31.5) 554 (37.6) 277 (38.6)
Doctoral degree 554 (13.0) 265 (12.7) 186 (12.6) 103 (14.3)
Residence
North America 4519 (92.6) 2023 (91.8) 1513 (92.3) 983 (94.6)
Middle East 297 (6.1) 160 (7.3) 87 (5.3) 50 (4.8)
Europe 38 (0.8) 7 (0.3) 27 (1.6) 4 (0.4)
Asia 15 (0.3) 7 (0.3) 6 (0.4) 2 (0.2)
Africa 11 (0.2) 6 (0.3) 5 (0.3) -





0–1 years 2583 (66.2) 1437 (70.4) 791 (60.7) 355 (63.7)
2–3 years 509 (13.0) 240 (11.8) 196 (15.0) 73 (13.1)
4–5 years 268 (6.9) 129 (6.3) 92 (7.1) 47 (8.4)
6–10 years 256 (6.6) 110 (5.4) 104 (8.0) 42 (7.5)
11–15 years 128 (3.3) 59 (2.9) 45 (3.5) 24 (4.3)






None 1735 (41.4) 942 (47.2) 507 (39.9) (30.8) 286
1–7 h 1607 (38.3) 718 (36.0) 468 (36.8) 421 (45.4)
8–16 h 267 (6.4) 104 (5.2) 95 (7.5) 68 (7.3)
17–32 h 224 (5.3) 91 (4.6) 72 (5.7) 61 (6.6)





treatment services 2785 (61.0) 1326 (62.3) 874 (62.9) 585 (56.1)
General interest/Learn 2537 (55.6) 1199 (56.3) 828 (59.6) 510 (48.9)
Want to become certified 2378 (52.1) 1159 (54.4) 776 (55.8) 443 (42.5)
Work related or
work requirement 801 (17.6) 421 (19.8) 189 (13.6) 191 (18.3)
Research and evaluation 721 (15.8) 314 (14.7) 292 (21.0) 115 (11.0)
* More than one reason can be selected.
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Table 2. Number of Trainees by Training Program 2016–2019.
Program Name (Alpha Order) Total (7761) 2019 (2274) 2018 (1829) 2017 (1888) 2016 (1770)
N (%) N (%) N (%) N (%) N (%)
Alaska Native Tribal Health Consortium 128 (1.6) 29 (1.3) 26 (1.4) 33 (1.7) 40 (2.3)
Arizona Tobacco Treatment Specialist Course 33 (0.4) 0 33 (1.8) * *
BREATHE Online Tobacco Treatment Specialist
Training Program 216 (2.8) 99 (4.4) 86 (4.7) 31 (1.6) *
The Breathing Association 299 (3.9) 68 (3.0) 106 (5.8) 75 (4.0) 50 (2.8)
Duke-UNC Tobacco Treatment Specialist
Training Program 365 (4.7) 120 (5.3) 153 (8.4) 92 (4.9) *
Tobacco Treatment Specialist Training and
Certificate Program, Duquesne University 430 (5.5) 230 (10.1) 77 (4.2) 50 (2.6) 73 (4.1)
Healthyways, a Sharecare Company 41 (0.5) 0 0 6 (0.3) 35 (2.0)
King Hussein Cancer Center Tobacco
Dependence Treatment Training 192 (2.5) 118 (5.2) 74 (4.0) * *
Tobacco Treatment Education & Training
Program, MaineHealth Center for Tobacco
Independence
49 (0.6) 5 (0.2) 8 (0.4) 18 (1.0) 18 (1.0)
Tobacco Treatment Specialist Training, Mayo
Clinic Nicotine Dependence Center 915 (11.8) 226 (9.9) 186 (10.2) 235 (12.4) 268 (15.1)
National Jewish Health® 93 (1.2) 33 (1.5) 38 (2.1) 14 (0.7) 8 (0.5)
Optum’s Quit For Life Program® 81 (1.0) 15 (0.7) 6 (0.3) 14 (0.7) 46 (2.6)
Rocky Mountain Tobacco Treatment Specialist
Training Program 300 (3.9) 108 (4.7) 16 (0.9) 78 (4.1) 98 (5.5)
Roswell Park Tobacco Treatment Specialist
Training Program 103 (1.3) 87 (3.8) 16 (0.9) * *
Rutgers Tobacco Dependence Program 425 (5.5) 149 (6.6) 93 (5.1) 81 (4.3) 102 (5.8)
Tobacco Treatment Specialist Course, Florida
State University 560 (7.2) 87 (3.8) 104 (5.7) 120 (6.4) 249 (14.1)
Tobacco Treatment Specialist Training and
Certification Program, College of Medicine,
Taibah University
36 (0.5) 36 (1.6) * * *
Tobacco Treatment Specialist Training Program,
University of Massachusetts Medical School 2101 (27.1) 318 (14.0) 354 (19.4) 790 (41.8) 639 (36.1)
ACT Center for Tobacco Treatment, Education
and Research, University of Mississippi
Medical Center Cancer Institute
608 (7.8) 139 (6.1) 208 (11.4) 162 (8.6) 99 (5.6)
Comprehensive Smoking Treatment Program,
University of Pennsylvania 180 (2.3) 51 (2.2) 48 (2.6) 36 (1.9) 45 (2.5)
Tobacco Treatment Training Program, The
University of Texas MD Anderson Cancer 457 (5.9) 246 (10.8) 158 (8.6) 53 (2.8) *
Tobacco Treatment Training Program, School
of Dentistry, West Virginia University 149 (1.9) 110 (4.8) 39 (2.1) * *
* Not yet accredited that year.
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Table 3. Tobacco Treatment Training Programs Accredited by the Council for Tobacco Treatment Training Programs through
2020.
Program Name Year Accredited Program Description
Tobacco Prevention and Control Program,
Wellness and Prevention Department,
Alaska Native Tribal Health Consortium
(ANTHC), Anchorage, AK
2008
The ANTHC training program aids health care
professionals develop and understand the required
skills in a manner that reflects the Alaska Native
spirit and addresses tobacco-related disparities in
Alaska. Delivered in-person (annually) and
virtually (quarterly), to date, ANTHC has trained
over 500 professionals.
Arizona Tobacco Treatment Specialist
Course, Mercy Care, Phoenix, AZ 2019
As a Medicaid health plan serving members in
Maricopa County Arizona, Mercy Care’s training
program focuses on providing high-quality
evidence-based treatment for Tobacco Use
Disorder (TUD) to plan members with serious
mental illness. The Mercy Care training program’s
mission is to train an internal treatment workforce
to deliver high-quality evidence-based treatment
for TUD to plan members.
BREATHE Online Tobacco Treatment
Specialist Training Program, College of
Nursing, University of Kentucky,
Lexington, KY
2017
The BREATHE training program offers an
asynchronous, fully online, self-paced training
program in which participants receive written and
virtual feedback on assignments using the Canvas
learning platform. Developed to meet the needs of
diverse professionals nationally and
internationally, the training model and modality
allows professionals to tailor a learning plan to
their interests and settings.
Tobacco Treatment Specialist Certification
Program, The Breathing Association,
Columbus, OH
2016
The Breathing Association training program is
focused on preparing health care and mental
health professionals to provide treatment for TUD
in diverse clinical and community settings. The
curriculum also focuses on best practices in the
development of tobacco treatment programs.
Duke-UNC Treatment Specialist Training
Program, Durham, NC 2017
The Duke-UNC training program is a collaborative
partnership between Duke University Smoking
Cessation Program, UNC Tobacco Intervention
Programs, and the Tobacco Prevention and Control
Branch of the North Carolina Division of Public
Health. The Duke-UNC training program offers
highly interactive in-person and virtual training
using a combination of didactic learning,
interactive exercises, and case studies. The
curriculum also provides training in tobacco
control policy, and guidance on developing
effective smoking cessation programs in
diverse settings.
Tobacco Treatment Specialist Training
and Certificate Program, Duquesne
University, Pittsburg, PA
2014
Taught by faculty pharmacists, the Duquesne
training program offers an enriched and unique
perspective into the pharmacotherapy used for
tobacco cessation.
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Table 3. Cont.
Program Name Year Accredited Program Description
Healthways, a Sharecare Company,
Franklin, TN 2012
Healthways has delivered an internal wellness and
tobacco cessation program since 2006. Healthways
training program is focused on training health and
wellness Coaches who work within the
Healthways spectrum of services.
King Hussein Cancer Center (KHCC)
Tobacco Dependence Treatment Training,
Amman, Jordan
2017
The KHCC training program is focused on
building the capacity, competence, and confidence
of professionals in Jordan and other countries in
the Eastern Mediterranean region. The KHCC
training is available in-person and virtually. The
virtual training aims to build a wide network of
tobacco treatment providers across the region,
provide a robust exchange of experiences, and
sustain the tobacco dependence treatment efforts
in Jordan and the Eastern Mediterranean region.
Tobacco Treatment Education & Training
Program, MaineHealth Center for
Tobacco Independence, Portland, ME
2012
The MaineHealth training program is an integral
part of a coordinated, collaborative statewide
effort to address tobacco use and exposure through
education, prevention, policy, treatment, and
training. The MaineHealth mission is “Making our
communities the healthiest in America through
reduction of tobacco use and through the
provision of evidence-based treatment, education,
policy development and research.” The
MaineHealth training focuses on developing a
workforce of highly trained Tobacco Treatment
Specialists in Maine.
Tobacco Treatment Specialist Training,
Mayo Clinic Nicotine Dependence Center,
Program, Rochester, MN
2010
Since 2010, the Mayo Clinic training program has
trained over 3000 professionals. The Mayo Clinic
training program offers a unique blended learning
experience which includes synchronous and
asynchronous virtual learning and/or in-person
training modalities. The Mayo Clinic program is
focused on preparing professionals to treat tobacco
dependence in diverse settings including hospitals,
community health centers, dental practices, public
health organizations, telephone quit lines, and
addiction and mental health centers.
National Jewish Health®, Denver, CO 2015
National Jewish Health® is the leading respiratory
hospital in the United States and the largest
nonprofit provider of telephone quitline services.
National Jewish Health’s training program is
focused on training professionals within the
National Jewish Health® organization including
all the Health and Wellness Coaches and the
quitline Quit Coaches, and other employees.
Professionals are trained to deliver in-person,
telephone, text, and chat-based interventions to
quitline participants and patients in the National
Jewish Health® hospitals and clinics.
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Optum’s Quit For Life Program®, Optum,
Eden Prairie, MN
2016
Optum is a leading health services innovation
company. The Quit For Life® training program is
offered to Quit Coaches who support Optum’s
Quit For Life Quit® treatment services. The Quit
For Life program has over 30 years of experience
operating tobacco quitline services to health plans,
employers and state quitlines. Optum’s virtual
training uses synchronous and asynchronous
methods to prepare Quit Coaches to deliver
interventions via telephone, text, chat and online
groups to a diverse population including adults,
youth, and vulnerable populations such as those
with behavioral health conditions.
Rocky Mountain Tobacco Treatment
Specialist (RMTTS) Training Program,
Department of Psychiatry, University of
Colorado Anschutz Medical Campus,
Aurora, CO
2015
The RMTTS training program is part of the
Behavioral Health and Wellness Program at the
University of Colorado, a multi-disciplinary center
of excellence for public policy, research, training,
and clinical care. The RMTTS training program’s
mission is to train interdisciplinary health care
providers and community and public health
professionals to become tobacco cessation
champions in their organizations and communities.
The RMTTS training program works with
communities, healthcare facilities, and public
health and governmental agencies to promote
tobacco treatment as part of overall health and
wellness in priority populations.
Roswell Park Tobacco Treatment
Specialist Training Program, Roswell
Park Comprehensive Cancer Center,
Buffalo, NY
2018
The mission of the Roswell Park training program
is to contribute to the professional development of
the tobacco treatment clinical and research
workforce in Western New York, in the United
States, and across the world. The Roswell Park
program is also focused on training Roswell Park
Cessation Services Quit Coaches. The curriculum
focuses on individual, telephone, and virtual
treatment modalities, provides hands-on
experience delivering an evidence-based treatment
manual, and is enhanced with in-depth content
about tobacco product marketing, tobacco product
development, and tobacco regulatory science.
Rutgers Tobacco Dependence Program,
Center for Tobacco Studies, Cancer
Institute of New Jersey, Robert Wood
Johnson Medical School, School of Public
Health, New Brunswick, NJ
2010
The Rutgers training program has been training
tobacco treatment specialists since 2001, with a
multidisciplinary training faculty consisting of
physicians, behavioral health clinicians, and public
health experts. The Rutgers program is dedicated
to reducing the harm caused by tobacco use for
those who need it most, by training professionals
to provide education and evidence-based
treatment, conduct innovative research, and
engage in advocacy.
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Tobacco Treatment Specialist Course,
College of Medicine, Florida State
University (FSU), Tallahassee, FL
2011
Since accreditation, the FSU program has trained
over 1100 professionals and paraprofessionals.
Training is provided by an interdisciplinary faculty
of physicians, clinicians, and public health experts
with extensive experience in treating tobacco use
disorders and tobacco control. The goal of the FSU
program is to prepare TTSs to treat tobacco users,
provide training to others, act as consultants in
addressing challenging situations, and implement
systems change strategies in health systems and
behavioral health programs.
Tobacco Treatment Specialist Training
and Certification Program (TTS-TCP),
College of Medicine, Taibah University,
Madinah Saudi Arabia
2019
The TTS-TCP aims to provide comprehensive,
practical and standardized training in tobacco
treatment and research for health care
professionals in Saudi Arabia, the Gulf
Cooperation Council (GCC) countries, and the
wider region. Taibah University aims to support
the GCC efforts to address a continuous increase in
the prevalence of tobacco smoking in the Gulf
region by providing high-quality, standardized
training in tobacco treatment. Although the
primary focus of the Taibah program is to train
health care workers in Saudi Arabia, it aims to be a
resource for workers in the neighboring countries.
In fact, professionals from other GCC countries
were among the attendees of the first course in
Taibah University in October of 2019.
Tobacco Treatment Specialist Training
Program, Center for Tobacco Treatment
Research and Training, University of
Massachusetts Medical School, Worcester,
MA
2012
Founded in 1999, the UMass training program
offers blended synchronous and asynchronous
virtual and in-person training modalities. The
mission of the UMass program is to increase access
to evidence-based tobacco dependence treatment
services across the world. The UMass program has
a unique structure with workshops delivered by
UMass faculty and UMass Certified Trainers
located in diverse settings throughout the world.
ACT Center for Tobacco Treatment,
Education and Research, University of
Mississippi Medical Center Cancer
Institute, Jackson, MS
2011
The ACT Center has trained TTSs in Mississippi
across the US and internationally since 1999. This
program attracts a broad range of professionals
who work in a variety of health care, academic,
community, and other settings. A unique aspect of
this program is that clinical skills are taught within
the context of hands-on mastery of the ACT Center
Tobacco Treatment clinical treatment protocol.
Substantial time is dedicated to hands-on practice
delivering this treatment protocol. This
manualized, evidence-based approach is the
product of many years of testing and experience
and represents an effective balance of
state-of-the-art clinical procedures.
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Comprehensive Smoking Treatment




The University of Pennsylvania’s training program
is highly interactive and delivered in both
in-person and virtual training modalities. The
University of Pennsylvania program is focused on
cultivating a deep understanding of the biological,
social, and environmental factors that influence the
tobacco epidemic. The program expects trainees to
develop new perspectives on tobacco dependence
and experience fundamental changes in their
approaches to the treatment of tobacco use
and dependence.
Tobacco Treatment Training Program,
The University of Texas MD Anderson
Cancer Center, Houston, TX
2017
The MD Anderson training program is focused on
training multidisciplinary health care providers as
well as community and public health professionals
seeking to become tobacco treatment and nicotine
addiction specialists and champions for their
organizations and communities. The MD
Anderson program offers onsite, traveling team,
and remotely delivered training. The program also
offers unique opportunities for on-going support
and continuous education for all TTSs through
weekly ECHO tele-mentoring sessions, called
Project TEACH.
Tobacco Treatment Training Program,
School of Dentistry, West Virginia
University, Morgantown, WV
2017
The WVU training program teaches
evidence-based tobacco treatment to a wide
variety of healthcare professionals. This mission is
accomplished with a multidisciplinary team of
expert faculty from dentistry, medicine, nursing,
pharmacy, social work, and public health. Training
is provided in a three-day in-person workshop but
also will be provided as part of the required
curricula of the WVU Schools of Dentistry,
Medicine, Nursing, Pharmacy, and Public Health.
Tobacco Treatment Specialist Training
Program, Memorial Sloan Kettering
Cancer Center, New York, NY
2020
The MSK training program is focused on training
clinicians and clinical researchers. Utilizing the
MSK Comskills Training Laboratory, the MSK
training program utilizes a unique blend of
hands-on learning with professional actors who
simulate live patient scenarios. Training is
delivered in synchronous virtual and in-person
training modalities.
Trainee professional background and work setting were diverse. (See Tables 4 and 5)
About 80% of respondents were from 13 professional backgrounds and nearly 20% were
from 16 less frequently reported professional backgrounds. The response rate for this item
was relatively low, 74%, which might reflect difficulty in answering the question among
trainees without mainstream professional backgrounds. Over half (50.4%) of trainees
worked in larger institutions such as hospitals, medical centers, or academic medical
centers; however, 42.7% worked in one of seven other settings, and 6.9% worked in one of
17 less frequently reported settings.
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Table 4. Primary professional background of trainees (n = 3848).
Profession Number (Percent)
Nursing 671 (17.4)
Social Work 361 (9.4)
Health Education 310 (8.1)
Physician 275 (7.1)
Mental Health Counselor or
Specialist—non-doctoral 260 (6.8)
Advanced Practice Nurse or Physician
Assistant 255 (6.6)
Respiratory Therapy 252 (6.5)
Pharmacy Professional 215 (5.6)
Psychologist 204 (5.3)
Alcohol and Substance Use Treatment
Professional 163 (4.2)
Public Health Professional 120 (3.1)
Administration or Management Professional 47 (1.2)
Dental Professional 46 (1.2)
Other * 669 (17.4)
* Reported by less than 1% of respondents, but includes such diverse professionals as health and wellness coaches,
registered dieticians, traditional or complementary medical professionals, and radiologic technologists.
Table 5. Trainee primary work setting (n = 4629).
Work Setting Number (Percent)
Hospital, Medical, or Academic Medical Center 2335 (50.4)
Community Health Center 528 (11.4)
Public Health 408 (8.8)
Counseling Centers 316 (6.8)
Tobacco Cessation Treatment Programs 268 (5.8)
Addiction Treatment 242 (5.2)
Wellness Program 171 (3.7)
Social Service Agency 43 (1.0)
Other * 318 (6.9)
* Reported by less than 1% of respondents, but includes such diverse work settings as dental practices, government
agencies, homeless shelters, research, health insurance companies, and the military.
The reasons for attending training, experience of trainees in the field of tobacco
treatment, and the amount of time devoted to tobacco treatment indicate that most trainees
were new to the tobacco treatment workforce. The most frequently reported reasons for
training were to implement tobacco treatment services (61%), to learn (56.6%), and to
become certified (52.1%). A meaningful proportion of trainees (15%) attended to improve
their tobacco-related research and evaluation skills. Two-thirds (n = 2583; 66.2%) were
new to the field having worked in tobacco treatment for 1 year or less. Nearly half of
those working 1 year or less (44.5%; n = 1735) reported 0 years of working in tobacco
treatment. Another 19.9% (n = 777) of trainees had worked in tobacco treatment for 5 years
or less. In terms of time spent delivering tobacco treatment services, 44.7% (n = 1874)
spent two days or less working in tobacco treatment. The number of hours per week
working in tobacco treatment was positively correlated with the number of years working
in tobacco treatment (Pearson correlation 0.24, p < 0.0001). The more years working in
tobacco treatment, the more hours per week trainees reported working in tobacco treatment.
See Table 1.
4. Discussion
The Council-accredited TTS training programs, diverse in terms of mission, setting,
and training modalities, appear to be contributing to the development of an emerging,
highly trained tobacco treatment workforce. The number of Council-accredited TTS train-
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ing programs and trainees has steadily increased in the last decade. Findings show a
28.5% increase in the number of trainees from 2016–2019. This increase coincides with
the addition of eight new training programs from 2016–2019, two of which are located in
the Eastern Mediterranean, a region with remarkably high tobacco smoking prevalence
rates and a tremendous need for accessible, high quality, tobacco treatment. Training is
an important step in developing the resources needed to provide access to tobacco treat-
ment [15] and understanding the nature of the training programs and the characteristics
of the trainees is key to developing a tobacco treatment workforce that meets tobacco
treatment needs worldwide.
Trainees were from diverse professional and educational backgrounds and worked
in a wide variety of medical, behavioral health, public health, and community settings
which suggests that the interdisciplinary approach to developing the training standards
was effective in meeting the needs of diverse professionals. Nonetheless, one of the most
striking characteristics of trainees was their inexperience with tobacco treatment. Over 40%
were not currently providing any tobacco treatment, and two-thirds had been providing
tobacco treatment for 1 year or less. Yet nearly two-thirds of trainees intended to implement
tobacco treatment services in their setting, and more than half were seeking TTS certification.
This suggests that the Council-accredited training programs are indeed developing an
emerging workforce with professionally diverse backgrounds seeking to identify as TTSs
as well as contributing to the development of programmatic tobacco treatment services.
The demographic background of this emerging workforce, however, has not been
particularly diverse. Trainees were primarily White (70%) and female (80%), about 14%
Black or African American, and centered in North America, with little change during
the observation period. While the two new programs in the Eastern Mediterranean have
the potential to increase diversity, efforts to enhance diversity and inclusion within all
programs is needed. A more diverse tobacco treatment workforce is key to meeting the
needs of the many marginalized groups that experience tobacco-related disparities [66].
Coordinated efforts to increase trainee demographic and regional diversity are needed and
well within the mission of the Council.
The primary catchment areas for many programs has been regional; however, the on-
set of the COVID-19 pandemic from SARS-CoV-2 virus in early 2020 caused nearly all
programs to cancel in-person workshops and develop virtual training opportunities that
have the potential to reach more diverse trainees. Virtual training opportunities also
might enable distant groups to benefit from the expertise of particular training programs.
For instance, health care settings across the world that treat individuals from the Eastern
Mediterranean for TUD can now potentially access virtual training tailored to treating
this population. Analyses of trainee data in the coming years will provide insight into
the impact of the proliferation of virtual TTS training opportunities on the number and
characteristics of trainees.
Nonetheless, many programs have a special niche within their institutions or within
their state or regional tobacco control programs and thus their missions are not necessarily
focused on volume or reach. With a few exceptions, the programs that have been training
TTSs for the longest period of time tended to train a higher proportion of trainees. For in-
stance, the University of Massachusetts program trained 27% of the trainees and the Mayo
Clinic program trained 11.8% of the trainees between 2016–2019. These programs have ded-
icated staff, were established about 20 years ago, and travel nationally and internationally,
which is likely to contribute to a higher volume of trainees.
Training a workforce in the evidence-based treatment of tobacco dependence is needed
to improve access to effective treatment for TUD [14], particularly in low and middle-
income countries. To this end, support and resources to develop training programs and
fund trainee attendance is needed. Funding from Global Bridges was used to support
attendance of some trainees at the King Hussein Comprehensive Cancer Center, but that
is likely to be the exception. While the Council does not collect data on how trainees
fund attendance, the high proportion of trainees who attend because they are sent by their
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employers as well as the high proportion of trainees who work in larger institutions such as
hospitals, medical centers, and academic medical centers suggests that a large proportion
of trainees’ attendance is paid by employers. New virtual training opportunities have
the potential to accelerate accessibility, but barriers remain including the cost of tuition,
engaging in 30–40 h of training time, and access to high-speed internet. Within the mission
of the Council is developing strategies to support attendance from demographically and
geographically diverse professionals; doing so might increase the number of trainees from
less well-supported organizations, from marginalized groups, and from low and middle-
income countries. Asynchronous virtual training opportunities and blended (synchronous
and asynchronous) training can help professionals train around busy work schedules.
Ensuring professionals are released from duties or compensated for the time they devote
to training would also help improve access. In the future, collecting the source of support
for attendance might be an important new addition to the Council’s minimum data set.
The strengths of this study include the characterization of multiple years of trainees
who completed TTS training within a large group of training partners, accredited by one
organization with one set of training standards. The large number of trainees allows for
some generalization. Being a descriptive study, however, there are no methods for making
causal conclusions about the nature of the programs and the characteristics of the trainees.
5. Conclusions
A highly skilled tobacco treatment workforce is a critical component in building
the infrastructure and systems of care to increase the accessibility of treatment for TUD.
The treatment of TUD is becoming more complex and tailoring treatment to address new
and traditional tobacco products is needed. The Council is committed to the development
and proliferation of training that meets the needs of a dynamic, diverse, and complex
population of tobacco users. Council-accredited TTS training programs are contributing to
the development of an emerging workforce prepared for the tobacco treatment challenges
of the 21st century. Developing strategies to support attendance from demographically
and geographically diverse professionals might increase the number of trainees from less
well-supported organizations, from marginalized groups, and from regions of the world
that experience tobacco-related inequities.
Supplementary Materials: The following are available online at https://www.mdpi.com/1660-4
601/18/5/2416/s1, Document S1: Tobacco Product Use Common in Certain Regions of the World.
References [67–74] are cited in the supplementary materials.
Author Contributions: C.E.S. led the conceptualization, methodology, formal analyses, and the first
draft writing, editing, review, and funding acquisition. A.A-Z., A.A., R.B., C.B., S.B., E.C., C.C., A.D.,
J.G., M.K.-H., F.H., T.H., V.H., C.K., F.L., J.M., H.M., C.M. (Crystal Meade), C.M. (Cara Messick),
S.K.M., C.W.M., T.P., E.S., T.S., M.S., J.R., and A.W. took part in data curation, writing review and
editing. J.R. and W.S. took part in project administration. W.S. also took part in writing review and
editing. E.C. took part in data validation, writing the first draft and writing review and editing.
All authors have read and agreed to the published version of the manuscript.
Funding: This work was supported by a grant from the National Institutes of Health National Cancer
Institute (R25CA233416).
Institutional Review Board Statement: The study was conducted according to the guidelines of the
Declaration of Helsinki. This project reports on data collected in established educational settings,
using normal and accredited education practices. The data included no identifying information and
no ability to trace the data back to any individual. There was no potential adverse impact on trainees
or instructors. The project that contributed support to this study was approved by Roswell Park
Comprehensive Cancer Center Institutional Review Board (I-455719).
Informed Consent Statement: This is an analysis of curated de-identified database collected by
the training programs in established educational settings using normal educational practices and
organized by the Council. Informed consent for human subjects was not applicable.
Int. J. Environ. Res. Public Health 2021, 18, 2416 15 of 17
Data Availability Statement: The data presented in this study are available on request and agreement
with the Council for Tobacco Treatment Training Programs, Inc. The data are not publicly available
but accessible with the appropriate data use agreement with the Council. Data requests should be
made to info@ctttp.org.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. AAAP. Nicotine Dependence in Translating Science. In Transforming Lives; American Academy of Addiction Psychiatry: East
Providence, RI, USA, 2015.
2. Gowing, L.R.; Ali, R.L.; Allsop, S.; Marsden, J.; Turf, E.E.; West, R.; Witton, J. Global statistics on addictive behaviours: 2014 status
report. Addiction 2015, 110, 904–919. [CrossRef]
3. WHO. WHO Report on the Global Tobacco Epidemic, 2017: Monitoring Tobacco Use and Prevention Policies; WHO: Geneva, Switzerland,
2017.
4. Öberg, M. Second-hand smoke: Assessing the environmental burden of disease at national and local levels. In WHO Environmental
Burden of Disease Series; World Health Organization: Geneva, Switzerland, 2010.
5. Öberg, M.; Jaakkola, M.S.; Woodward, A.; Peruga, A.; Prüss-Ustün, A. Worldwide burden of disease from exposure to second-hand
smoke: A retrospective analysis of data from 192 countries. Lancet 2011, 377, 139–146. [CrossRef]
6. WHO. Tobacco. Available online: https://www.who.int/news-room/fact-sheets/detail/tobacco (accessed on 24 February 2021).
7. Jha, P. Avoidable global cancer deaths and total deaths from smoking. Nat. Rev. Cancer 2009, 9, 655–664. [CrossRef]
8. Mathers, C.D.; Loncar, D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006, 3, e442.
[CrossRef]
9. Goodchild, M.; Nargis, N.; D’Espaignet, E.T. Global economic cost of smoking-attributable diseases. Tob. Control. 2018, 27, 58–64.
[CrossRef] [PubMed]
10. Goodchild, M.F.; Guo, H.; Annoni, A.; Bian, L.; De Bie, K.; Campbell, F.; Craglia, M.; Ehlers, M.; Van Genderen, J.; Jackson, D.; et al.
Next-generation Digital Earth. Proc. Natl. Acad. Sci. USA 2012, 109, 11088–11094. [CrossRef]
11. WHO Regional Office for the Eastern Mediterranean. Jordan: Making the Economic Case for Tobacco Control Action in Jordan; World
Health Organization: Geneva, Switzerland, 2019.
12. Loring, B. Tobacco and Inequities: Guidance for Addressing Inequities in Tobacco-Related Harm; World Health Organization: Geneva,
Switzerland, 2014.
13. Barnoya, J.; Glynn, T. Reducing global health inequities through tobacco control. Cancer Causes Control. 2012, 23, 7–9. [CrossRef]
[PubMed]
14. WHO. WHO Framework Convention on Tobacco Control; WHO: Geneva, Switzerland, 2003.
15. Kruse, G.R.; Rigotti, N.A.; Raw, M.; McNeill, A.; Murray, R.; Piné-Abata, H.; Bitton, A.; McEwen, A. Tobacco Dependence
Treatment Training Programs: An International Survey. Nicotine Tob. Res. 2015, 18, 1012–1018. [CrossRef]
16. Khattab, A.; Javaid, A.; Iraqi, G.; Alzaabi, A.; Ben Kheder, A.; Koniski, M.-L.; Shahrour, N.; Taright, S.; Idrees, M.; Polatli, M.; et al.
Smoking habits in the Middle East and North Africa: Results of the BREATHE study. Respir. Med. 2012, 106, S16–S24. [CrossRef]
17. WHO. Advisory Note: Waterpipe Tobacco Smoking: Health Effects, Research Needs and Recommended Actions for Regulators; World
Health Organization: Geneva, Switzerland, 2015.
18. Al-Houqani, M.; Leinberger-Jabari, A.; Al Naeemi, A.; Al Junaibi, A.; Al Zaabi, E.; Oumeziane, N.; Kazim, M.; Al Maskari, F.;
Al Dhaheri, A.; Wareth, L.A.; et al. Patterns of tobacco use in the United Arab Emirates Healthy Future (UAEHFS) pilot study.
PLoS ONE 2018, 13, e0198119. [CrossRef]
19. WHO. WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000–2025, 2nd ed.; World Health Organization: Geneva,
Switzerland, 2018.
20. Hassounah, S.; Rawaf, D.; Khoja, T.; Rawaf, S.; Hussein, M.; Qidwai, W.; Majeed, A. Tobacco control efforts in the Gulf Cooperation
Council countries: Achievements and challenges. East. Mediterr. Health J. 2014, 20, 508–513. [CrossRef]
21. WHO Regional Office for the Eastern Mediterranean. Regional Framework for Action to Implement the United Nations Political
Declaration on Noncommunicable Diseases: Annex to Resolution EM/RC59/R.2; World Health Organization: Geneva, Switzerland,
2012.
22. U.S. Department of Health and Human Services. Tobacco Use Among U.S. Racial/Ethnic Minority Groups—African Americans,
American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General; U.S.
Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease
Prevention and Health Promotion, Office on Smoking and Health: Washington, DC, USA, 1998.
23. National Center for Chronic Disease Prevention and Health Promotion. Available online: https://www.cdc.gov/chronicdisease/
index.htm (accessed on 24 February 2021).
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Publishing:
Washington, DC, USA, 2014.
25. DHHS. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General; U.S. Department of Health
and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2014.
Int. J. Environ. Res. Public Health 2021, 18, 2416 16 of 17
26. U.S. Department of Health and Human Services. Smoking Cessation. In A Report of the Surgeon General. U.S. Department of Health
and Human Services; Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2020.
27. Babb, S. Quitting Smoking among Adults—United States, 2000–2015. MMWR Morb. Mortal Wkly. Rep. 2017, 65, 1457–1464.
[CrossRef]
28. Abughosh, S.; Wu, I.-H.; Hawari, F.; Peters, R.J.; Yang, M.; Crutchley, R.; Essien, E.J. Predictors of Intention to Quit Cigarette
Smoking among Jordanian Adult. Epidemiol. Open Access 2011, 1, 1–7. [CrossRef]
29. Zhu, S.-H.; Sun, J.Y.; Bonnevie, E.; Cummins, S.E.; Gamst, A.; Yin, L.; Lee, M. Four hundred and sixty brands of e-cigarettes and
counting: Implications for product regulation. Tob. Control. 2014, 23, iii3–iii9. [CrossRef]
30. Bhatnagar, A.; Whitsel, L.P.; Blaha, M.J.; Huffman, M.D.; Krishan-Sarin, S.; Maa, J.; Rigotti, N.; Robertson, R.M.; Warner, J.J.;
on behalf of the American Heart Association. New and Emerging Tobacco Products and the Nicotine Endgame: The Role of
Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory from the American Heart
Association. Circ. 2019, 139, e937–e958. [CrossRef] [PubMed]
31. Anthonisen, N.R. The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial. Ann. Intern.
Med. 2005, 142, 233–239. [CrossRef] [PubMed]
32. Fiore, M.C. Treating tobacco use and dependence: 2008 update. In Clinical Practice Guideline; Public Health Service: Rockville,
MD, USA, 2008.
33. Kasza, K.A.; Hyland, A.J.; Borland, R.; McNeill, A.D.; Bansal-Travers, M.; Fix, B.V.; Hammond, D.; Fong, G.T.; Cummings,
K.M. Effectiveness of stop-smoking medications: Findings from the International Tobacco Control (ITC) Four Country Survey.
Addiction 2013, 108, 193–202. [CrossRef] [PubMed]
34. Brose, L.S.; McEwen, A.; Michie, S.; West, R.; Chew, X.Y.; Lorencatto, F. Treatment manuals, training and successful provision of
stop smoking behavioural support. Behav. Res. Ther. 2015, 71, 34–39. [CrossRef]
35. Brose, L.S.; McEwen, A.; West, R. Does it matter who you see to help you stop smoking? Short-term quit rates across specialist
stop smoking practitioners in England. Addiction 2012, 107, 2029–2036. [CrossRef] [PubMed]
36. Brose, L.S.; West, R.; McEwen, A. How stable are stop smoking practitioner success rates over time? Transl. Behav. Med. 2014, 4,
220–225. [CrossRef]
37. Brose, L.S.; West, R.; Michie, S.; McEwen, A. Changes in success rates of smoking cessation treatment associated with take up of a
national evidencebased training programme. Prev. Med. 2014, 69, 1–4. [CrossRef]
38. McDermott, M.S.; Beard, E.; Brose, L.S.; West, R.; McEwen, A. Factors Associated With Differences in Quit Rates Between
“Specialist” and “Community” Stop-Smoking Practitioners in the English Stop-Smoking Services. Nicotine Tob. Res. 2012, 15,
1239–1247. [CrossRef]
39. Brose, L.S.; West, R.; McDermott, M.S.; Fidler, J.A.; Croghan, E.; McEwen, A. What makes for an effective stop-smoking service?
Thorax 2011, 66, 924–926. [CrossRef]
40. WHO. WHO Report on the Global Tobacco Epidemic; WHO: Geneva, Switzerland, 2019.
41. Warren, G.W.; Marshall, J.R.; Cummings, K.M.; Toll, B.; Gritz, E.R.; Hutson, A.; Dibaj, S.; Herbst, R.; Dresler, C. Practice Patterns
and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients. J. Thorac. Oncol. 2013, 8,
543–548. [CrossRef]
42. Twardella, D.; Brenner, H. Lack of training as a central barrier to the promotion of smoking cessation: A survey among general
practitioners in Germany. Eur. J. Public Health 2005, 15, 140–145. [CrossRef] [PubMed]
43. Jradi, H. Awareness, practices, and barriers regarding smoking cessation treatment among physicians in Saudi Arabia. J. Addict.
Dis. 2017, 36, 53–59. [CrossRef] [PubMed]
44. Rojewski, A.M.; Bailey, S.R.; Bernstein, S.L.; A Cooperman, N.; Gritz, E.R.; A Karam-Hage, M.; E Piper, M.; A Rigotti, N.; Warren,
G.W. Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States. Nicotine Tob. Res. 2019, 21,
1453–1461. [CrossRef] [PubMed]
45. Kruse, G.R.; Rigotti, N.A.; Raw, M.; McNeill, A.; Murray, R.; Piné-Abata, H.; Bitton, A.; McEwen, A. Content and Methods used to
Train Tobacco Cessation Treatment Providers: An International Survey. J. Smok. Cessat. 2017, 12, 213–220. [CrossRef]
46. McDermott, M.S.; West, R.; Brose, L.S.; McEwen, A. Self-reported practices, attitudes and levels of training of practitioners in the
English NHS Stop Smoking Services. Addict. Behav. 2012, 37, 498–506. [CrossRef]
47. Stead, M.; Angus, K.; Holme, I.; Cohen, D.; Tait, G. Factors influencing European GPs’ engagement in smoking cessation:
A multi-country literature review. Br. J. Gen. Pr. 2009, 59, 682–690. [CrossRef]
48. Vogt, F.; Hall, S.; Marteau, T.M. General practitioners’ and family physicians’ negative beliefs and attitudes towards discussing
smoking cessation with patients: A systematic review. Addiction 2005, 100, 1423–1431. [CrossRef]
49. Vogt, F.; Hall, S.; Marteau, T.M. General practitioners’ beliefs about effectiveness and intentions to prescribe smoking cessation
medications: Qualitative and quantitative studies. BMC Public Health 2006, 6, 277. [CrossRef] [PubMed]
50. Kotz, D.; Brown, J.; West, R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the “real
world”. Mayo Clin. Proc. 2014, 89, 1360–1367. [CrossRef]
51. Song, F.; Maskrey, V.; Blyth, A.; Brown, T.J.; Barton, G.R.; Aveyard, P.; Notley, C.; Holland, R.; Bachmann, M.O.; Sutton, S.; et al.
Differences in Longer-Term Smoking Abstinence After Treatment by Specialist or Nonspecialist Advisors: Secondary Analysis of
Data From a Relapse Prevention Trial. Nicotine Tob. Res. 2015, 18, 1061–1066. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2021, 18, 2416 17 of 17
52. Carter, G.T.; Javaher, S.P.; Nguyen, M.H.; Garret, S.; Carlini, B.H. Re-branding cannabis: The next generation of chronic pain
medicine? Pain Manag. 2015, 5, 13–21. [CrossRef] [PubMed]
53. Kalkhoran, S.; Thorndike, A.N.; Rigotti, N.A.; Fung, V.; Baggett, T.P. Cigarette Smoking and Quitting-Related Factors Among US
Adult Health Center Patients with Serious Mental Illness. J. Gen. Intern. Med. 2019, 34, 986–991. [CrossRef] [PubMed]
54. Diamanti, A.; Papadakis, S.; Schoretsaniti, S.; Rovina, N.; Vivilaki, V.; Gratziou, C.; Katsaounou, P.A. Smoking cessation in
pregnancy: An update for maternity care practitioners. Tob. Induc. Dis. 2019, 17, 57. [CrossRef] [PubMed]
55. CAN-ADAPTT. Canadian Smoking Cessation Clinical Practice Guideline; Centre for Addiction and Mental Health: Toronto, ON,
Canada, 2011.
56. NICE. Smoking Cessation: Supporting People to Stop Smoking; National Institute for Health and Clinical Excellence: Manchester, UK,
2013.
57. Health, M.O. New Zealand Smoking Cessation Guidelines; Ministry of Health: Wellington, New Zealand, 2017.
58. Schauer, G.L. Health-care Provider Screening and Advice for Smoking Cessation among Smokers with and without COPD:
2009-2010 National Adult Tobacco Survey. Chest 2016, 149, 676–684. [CrossRef]
59. Vidrine, J.I. Ask-Advise-Connect: A new approach to smoking treatment delivery in health care settings. JAMA Intern. Med. 2013,
173, 458–464. [CrossRef]
60. Vidrine, J.I. The Ask-Advise-Connect approach for smokers in a safety net healthcare system: A group-randomized trial. Am. J.
Prev. Med. 2013, 45, 737–741. [CrossRef]
61. Sheffer, C.E.; Stein, J.S.; Petrucci, C.; Mahoney, M.C.; Johnson, S.; Giesie, P.; Carl, E.; Krupski, L.; Tegge, A.N.; Reid, M.E.; et al.
Tobacco Dependence Treatment in Oncology: Initial Patient Clinical Characteristics and Outcomes from Roswell Park Compre-
hensive Cancer Center. Int. J. Environ. Res. Public Health 2020, 17, 3907. [CrossRef]
62. Burke, M.V.; Ebbert, J.O.; Schroeder, D.R.; McFadden, D.D.; Hays, J.T. Treatment Outcomes from a Specialist Model for Treating
Tobacco Use Disorder in a Medical Center. Medicine (Baltim.) 2015, 94, e1903. [CrossRef] [PubMed]
63. Joseph, A.M.; Rothman, A.J.; Almirall, D.; Begnaud, A.; Chiles, C.; Cinciripini, P.M.; Fu, S.S.; Graham, A.L.; Lindgren, B.R.; Melzer,
A.C.; et al. Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of
Lung Cancer Screening) Collaboration. Am. J. Respir. Crit. Care Med. 2018, 197, 172–182. [CrossRef]
64. Bitton, A.; Raw, M.; Richards, A.; McNeill, A.; Rigotti, N.A. A comparison of four international surveys of tobacco dependence
treatment provision: Implications for monitoring the Framework Convention on Tobacco Control. Addiction. 2010, 105, 2184–2191.
[CrossRef] [PubMed]
65. Sheffer, C.E. Increasing the quality and availability of evidence-based treatment for tobacco dependence through unified
cerification of tobacco treatment specialists. J. Smok. Cessat. 2015. [CrossRef]
66. Fagan, P.; Moolchan, E.T.; Lawrence, D.; Fernander, A.; Ponder, P.K. Identifying health disparities across the tobacco continuum.
Addiction 2007, 102, 5–29. [CrossRef] [PubMed]
67. Kyaing, N.; Sinha, D.; Islam, M.; Rinchen, S. Social, economic and legal dimensions of tobacco and its control in South-East Asia
region. Indian J. Public Health 2011, 55, 161–168. [CrossRef] [PubMed]
68. Sreeramareddy, C.T.; Pradhan, P.M.S.; Mir, I.A.; Sin, S. Smoking and smokeless tobacco use in nine South and Southeast Asian
countries: Prevalence estimates and social determinants from Demographic and Health Surveys. Popul. Health Metrics 2014, 12,
22. [CrossRef]
69. Vupputuri, S.; Hajat, C.; Al-Houqani, M.; Osman, O.; Sreedharan, J.; Ali, R.; E Crookes, A.; Zhou, S.; E Sherman, S.; Weitzman, M.
Midwakh/dokha tobacco use in the Middle East: Much to learn. Tob. Control. 2014, 25, 236–241. [CrossRef] [PubMed]
70. Tabuchi, T.; Gallus, S.; Shinozaki, T.; Nakaya, T.; Kunugita, N.; Colwell, B. Heat-not-burn tobacco product use in Japan:
Its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tob. Control.
2018, 27, e25–e33. [CrossRef]
71. Ali, F.R.M.; Diaz, M.C.; Vallone, D.; Tynan, M.A.; Cordova, J.; Seaman, E.L.; Trivers, K.F.; Schillo, B.A.; Talley, B.; King, B.A.
E-cigarette Unit Sales, by Product and Flavor Type—United States, 2014–2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69,
1313–1318. [CrossRef] [PubMed]
72. Weaver, S.R.; Majeed, B.A.; Pechacek, T.F.; Nyman, A.L.; Gregory, K.R.; Eriksen, M.P. Use of electronic nicotine delivery systems
and other tobacco products among USA adults, 2014: Results from a national survey. Int. J. Public Health 2016, 61, 177–188.
[CrossRef] [PubMed]
73. Llp, A.A. Electronic Cigarette Market by Product Type, Flavor and Distribution Channel—Global Opportunity Analysis and
Industry Forecast 2017–2023. Available online: https://www.researchandmarkets.com/reports/4458933/electronic-cigarette-
market-by-product-type (accessed on 24 February 2021).
74. Grana, R.A.; Ling, P.M. Smoking Revolution: A Content Analysis of Electronic Cigarette Retail Websites. Am. J. Prev. Med. 2014,
46, 395–403. [CrossRef] [PubMed]
